摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-ethyl-1-tosyl-1H-indole | 1192805-45-0

中文名称
——
中文别名
——
英文名称
2-ethyl-1-tosyl-1H-indole
英文别名
2-Ethyl-1-(4-methylphenyl)sulfonylindole
2-ethyl-1-tosyl-1H-indole化学式
CAS
1192805-45-0
化学式
C17H17NO2S
mdl
——
分子量
299.393
InChiKey
IJTZGZSNYLBEQK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    47.4
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-ethyl-1-tosyl-1H-indole正丁基锂 、 potassium hydroxide 、 zinc(II) chloride 作用下, 以 四氢呋喃甲醇正己烷 为溶剂, 反应 23.83h, 生成 benzyl 2-(2-ethyl-1H-indol-3-yl)acetate
    参考文献:
    名称:
    Design and Synthesis of Indomethacin Analogues That Inhibit P-Glycoprotein and/or Multidrug Resistant Protein without Cox Inhibitory Activity
    摘要:
    We designed and synthesized conformationally restricted analogues and regioisomers of the nonsteroidal anti-inflammatory drug indomethacin. Evaluation of the inhibitory effects of these compounds on COX, P-glycoprotein, and multidrug resistance indicated that NSAIDS modulation of multidrug-resistant P-glycoprotein and multidrug-resistant protein-1 is not associated with COX-1 and COX-2 inhibitory activities.
    DOI:
    10.1021/jm301084z
  • 作为产物:
    描述:
    N-p-toluenesulfonyl-2-(2-ethylethynyl)aniline 在 caesium carbonatecopper(l) chloride 作用下, 以 乙腈 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 6.0h, 以93.5%的产率得到2-ethyl-1-tosyl-1H-indole
    参考文献:
    名称:
    一种N-对甲苯磺酰基-2-取代吲哚类化合物的催化合成方法
    摘要:
    本发明公开的N‑对甲苯磺酰基‑2‑取代吲哚类化合物的催化合成方法,包括:常温常压下,将N‑对甲苯磺酰基‑2‑炔基取代的苯胺溶于乙腈中,N‑对甲苯磺酰基‑2‑炔基取代的苯胺与乙腈的摩尔体积比为1:1mmol/mL,得到N‑对甲苯磺酰基‑2‑炔基取代的苯胺的乙腈溶液;再向乙腈溶液中加入氯化亚铜和碳酸铯,氯化亚铜和碳酸铯的摩尔用量分别为N‑对甲苯磺酰基‑2‑炔基取代的苯胺摩尔用量的5%;之后,室温搅拌6小时,反应生成N‑对甲苯磺酰基‑2‑取代吲哚类化合物。该合成方法的成本低、收率高,其制备1g的N‑对甲苯磺酰基‑2‑取代吲哚类化合物所需催化剂的成本较现有以铑催化剂为催化剂的合成方法降低3个数量级,收率提高至89.1~97.0%。
    公开号:
    CN109651228B
点击查看最新优质反应信息

文献信息

  • Synthesis of Functionalized Indoles via Palladium-Catalyzed Aerobic Cycloisomerization of <i>o</i>-Allylanilines Using Organic Redox Cocatalyst
    作者:Xiao-Shan Ning、Mei-Mei Wang、Jian-Ping Qu、Yan-Biao Kang
    DOI:10.1021/acs.joc.8b01999
    日期:2018.11.2
    A scalable and practical synthesis of functionalized indoles via Pd-tBuONO cocatalyzed aerobic cycloisomerization of o-allylanilines is reported. Using molecular oxygen as a terminal oxidant, a series of substituted indoles were prepared in moderate to good yields. The avoidance of hazardous oxidants, heavy-metal cocatalysts, and high boiling point solvents such as DMF and DMSO enables this method
    报道了通过Pd- t BuONO共催化邻烯丙基苯胺的好氧环异构化可规模化和实用地合成官能化的吲哚。使用分子氧作为末端氧化剂,以中等至良好的产率制备了一系列取代的吲哚。避免使用有害的氧化剂,重金属助催化剂和高沸点溶剂(例如DMF和DMSO),可使该方法应用于药物合成。吲哚美辛的实用克级合成证明了其应用潜力。
  • Aromatic Enamide/Ene Metathesis toward Substituted Indoles and Its Application to the Synthesis of Indomethacins
    作者:Yayoi Kasaya、Kosuke Hoshi、Yukiyoshi Terada、Atsushi Nishida、Satoshi Shuto、Mitsuhiro Arisawa
    DOI:10.1002/ejoc.200900520
    日期:2009.9
    A steric and electronic effect on enamide/ene metathesis, a novel preparation of 2-substituted indoles and 3-substituted indoles using enamide-ene metathesis as a key reaction, and its application to the synthesis of indomethacin are described. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
    描述了烯酰胺/烯复分解的空间和电子效应,使用烯酰胺 - 烯复分解作为关键反应制备 2-取代吲哚和 3-取代吲哚的新方法,及其在吲哚美辛合成中的应用。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
  • Tandem Phospha‐Michael Addition/ <i>N</i> ‐Acylation/ Intramolecular Wittig Reaction of aza‐ <i>o</i> ‐Quinone Methides: Approaches to 2,3‐Disubstituted Indoles
    作者:Ting‐Bi Hua、Fei Chao、Long Wang、Chen‐Yang Yan、Cong Xiao、Qing‐Qing Yang、Wen‐Jing Xiao
    DOI:10.1002/adsc.202000343
    日期:2020.7.16
    A tandem phospha‐Michael addition/N‐acylation/intramolecular Wittig reaction of in situ formed aza‐o‐QMs is disclosed. This approach features high functional group tolerance and provides a convenient and practical access to biologically significant indole derivatives (37 examples, up to 91% yield) under mild reaction conditions.
    一种串联磷迈克尔加成/ Ñ酰化分子内形成的原位Wittig反应氮杂/ ö -QMs中公开。该方法具有高度的官能团耐受性,在温和的反应条件下,可方便实用地获得生物学上重要的吲哚衍生物(37个实例,产率高达91%)。
  • A Synthetic Route to 2-Alkyl Indoles via Thiophenol-Mediated Ring-Opening of <i>N</i>-Tosylaziridines Followed by Copper Powder-Mediated C–N Cyclization/Aromatization
    作者:Masthanvali Sayyad、Yerramsetti Nanaji、Manas K. Ghorai
    DOI:10.1021/acs.joc.5b02251
    日期:2015.12.18
    A simple strategy for the syntheses of 2-alkyl indoles via regioselective ring-opening of 2-(2-haloaryl)-3-alkyl-N-tosylaziridines with thiophenol, followed by copper powder-mediated intramolecular C-N cyclization and subsequent aromatization by the elimination of thiophenol, with good yields is described. Utilizing this protocol, 2-carboxyindole has been synthesized easily.
  • Indomethacin Analogues that Enhance Doxorubicin Cytotoxicity in Multidrug Resistant Cells without Cox Inhibitory Activity
    作者:Mitsuhiro Arisawa、Yayoi Kasaya、Tohru Obata、Takuma Sasaki、Mika Ito、Hiroshi Abe、Yoshihiro Ito、Akihito Yamano、Satoshi Shuto
    DOI:10.1021/ml100292y
    日期:2011.5.12
    Conformationally restricted indomethacin analogues were designed and prepared from the corresponding 2-substituted indoles, which were synthesized by a one-pot isomerization/enamide-ene metathesis as the key reaction. Conformational analysis by calculations, NMR studies, and X-ray crystallography suggested that these analogues were conformationally restricted in the s-cis or the s-trans form due to the 2-substituent as expected. Their biological activities on cyclooxygenase-1 (COX-1) inhibition, cyclooxygenase-2 (COX-2) inhibition, and modulation of MRP-1-mediated multidrug resistance (MDR) are described. Some of these indomethacin analogues enhanced doxorubicin cytotoxicity, although they do not have any COX inhibitory activity, which suggests that the MDR-modulating effect of an NSAID can be unassociated with its COX-inhibitory activity. This may be an entry into the combination chemotherapy of doxorubicin with a MDR modulator.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐